Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2013

01-06-2013 | Case Report

Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization

Authors: Haruka Yoshida, Hiroki Takahashi, Hiromichi Akoshima, Nobuyuki Chida, Kenji Noguchi, Nobukazu Tanabe, Yutaka Mano, Katsuaki Ukai, Keiichi Tadokoro

Published in: Clinical Journal of Gastroenterology | Issue 3/2013

Login to get access

Abstract

In January 2008, a 67-year-old woman was admitted to our hospital because of hepatitis C virus-related cirrhosis and hepatocellular carcinoma (HCC). In February 2010, she had tarry stools and anemia resulting from gastric antral vascular ectasia (GAVE). Argon plasma coagulation (APC) treatment for GAVE was performed at that time. She revisited our hospital in July 2010 because of tarry stools and anemia caused by GAVE recurrence, which required 5 APC sessions and blood transfusion to control the bleeding. In October 2010, she arrived at our hospital by ambulance because of hemorrhagic shock resulting from GAVE recurrence. Despite performing 5 APC sessions and multiple blood transfusions, the tarry stools and anemia persisted during the hospitalization period. In December 2010 and January 2011, second-stage selective transcatheter arterial embolization (TAE) of the right gastric and right gastroepiploic arteries using microcoils was performed for the treatment of the refractory GAVE. Upper gastrointestinal endoscopy performed after TAE revealed the disappearance of mucosal diffuse spotty redness. In addition, no complications such as gastric ulcer and necrosis were observed. Selective TAE, effectively resolved the GAVE and anemia, and no recurrence has been observed during the last 24 months. Therefore, TAE may be a safe and radical treatment for refractory GAVE.
Literature
1.
go back to reference Payen J, Cales P, Voigt J, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138–44.PubMedCrossRef Payen J, Cales P, Voigt J, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138–44.PubMedCrossRef
2.
go back to reference Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36:68–72.PubMedCrossRef Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36:68–72.PubMedCrossRef
3.
go back to reference Terawaki H, Kobayashi S, Kato J, et al. A case report of hemodialysis patient who presented recurrent bleeding from gastric antral vascular ectasia (GAVE) associated with liver cirrhosis: the effectiveness of trans-arterial embolization to bilateral gastric arteries. J Jpn Soc Dial Ther. 2008;41:803–8.CrossRef Terawaki H, Kobayashi S, Kato J, et al. A case report of hemodialysis patient who presented recurrent bleeding from gastric antral vascular ectasia (GAVE) associated with liver cirrhosis: the effectiveness of trans-arterial embolization to bilateral gastric arteries. J Jpn Soc Dial Ther. 2008;41:803–8.CrossRef
4.
go back to reference Rider JA, Klotz AP, Kirsner JB. Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage. Gastroenterology. 1953;24:118–23.PubMed Rider JA, Klotz AP, Kirsner JB. Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage. Gastroenterology. 1953;24:118–23.PubMed
5.
go back to reference Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–70.PubMed Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–70.PubMed
6.
go back to reference Lee FL, Costello F, Flanagan N, et al. Diffuse antral vascular ectasia. Gastrointest Endosc. 1984;30:87–90.PubMedCrossRef Lee FL, Costello F, Flanagan N, et al. Diffuse antral vascular ectasia. Gastrointest Endosc. 1984;30:87–90.PubMedCrossRef
7.
go back to reference Sebastian S, O’Morain CA, Buckley MJ. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther. 2003;18:157–65.PubMedCrossRef Sebastian S, O’Morain CA, Buckley MJ. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther. 2003;18:157–65.PubMedCrossRef
8.
go back to reference Gostout CJ, Viggiano TR, Ahlquist DA, et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256–63.PubMedCrossRef Gostout CJ, Viggiano TR, Ahlquist DA, et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256–63.PubMedCrossRef
9.
go back to reference Sato T, Yamazaki K, Akaike J, et al. Endoscopic band ligation for refractory gastric antral vascular ectasia associated with liver cirrhosis. Clin J Gastroenterol. 2011;4:108–11.CrossRef Sato T, Yamazaki K, Akaike J, et al. Endoscopic band ligation for refractory gastric antral vascular ectasia associated with liver cirrhosis. Clin J Gastroenterol. 2011;4:108–11.CrossRef
10.
go back to reference Moss SF, Ghosh P, Thomas DM, et al. Gastric antral vascular ectasia: maintenance treatment with estrogen-progesterone. Gut. 1992;33:715–7.PubMedCrossRef Moss SF, Ghosh P, Thomas DM, et al. Gastric antral vascular ectasia: maintenance treatment with estrogen-progesterone. Gut. 1992;33:715–7.PubMedCrossRef
11.
go back to reference McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750–2.PubMedCrossRef McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750–2.PubMedCrossRef
12.
go back to reference Peterson A, Varga J. Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis? Curr Rheumatol Rep. 2010;12:4–7.PubMedCrossRef Peterson A, Varga J. Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis? Curr Rheumatol Rep. 2010;12:4–7.PubMedCrossRef
13.
go back to reference Sargeant IR, Loizou LA, Rampton D, et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993;34:470–5.PubMedCrossRef Sargeant IR, Loizou LA, Rampton D, et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993;34:470–5.PubMedCrossRef
14.
go back to reference Fuccio L, Zagari RM, Serrani M, et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion. 2009;79:143–50.PubMedCrossRef Fuccio L, Zagari RM, Serrani M, et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion. 2009;79:143–50.PubMedCrossRef
15.
go back to reference Gross SA, Al-Haddad M, Gill KRS, et al. Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc. 2008;67:324–7.PubMedCrossRef Gross SA, Al-Haddad M, Gill KRS, et al. Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc. 2008;67:324–7.PubMedCrossRef
16.
go back to reference Lecleire S, Ben-Soussan E, Antonietti M, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc. 2008;67:219–25.PubMedCrossRef Lecleire S, Ben-Soussan E, Antonietti M, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc. 2008;67:219–25.PubMedCrossRef
17.
go back to reference Nakamura S, Mitsunaga A, Konishi H, et al. Long-term follow up of gastric vascular ectasia treated by argon plasma coagulation. Dig Endosc. 2006;18:128–33.CrossRef Nakamura S, Mitsunaga A, Konishi H, et al. Long-term follow up of gastric vascular ectasia treated by argon plasma coagulation. Dig Endosc. 2006;18:128–33.CrossRef
18.
go back to reference Je Y, Schutz FA, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncology. 2009;10:967–74.PubMedCrossRef Je Y, Schutz FA, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncology. 2009;10:967–74.PubMedCrossRef
19.
go back to reference Parente F, Petrillo M, Vago F, et al. The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases. Endoscopy. 1995;27:203–6.PubMedCrossRef Parente F, Petrillo M, Vago F, et al. The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases. Endoscopy. 1995;27:203–6.PubMedCrossRef
20.
go back to reference Robertson I, Tait N, Jackson J. Vascular ectasia of the gastric antrum: angiographic findings. Am J Roentgenol. 1996;166:87–9.CrossRef Robertson I, Tait N, Jackson J. Vascular ectasia of the gastric antrum: angiographic findings. Am J Roentgenol. 1996;166:87–9.CrossRef
21.
go back to reference Ashiya E, Yagi N, Shiomi H, et al. A case report of gastric vascular ectasia patient successfully treated by trans-arterial embolization despite the inefficiency of argon plasma coagulation. Jpn J Gastroenterol. 2003;100:A304. Ashiya E, Yagi N, Shiomi H, et al. A case report of gastric vascular ectasia patient successfully treated by trans-arterial embolization despite the inefficiency of argon plasma coagulation. Jpn J Gastroenterol. 2003;100:A304.
Metadata
Title
Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization
Authors
Haruka Yoshida
Hiroki Takahashi
Hiromichi Akoshima
Nobuyuki Chida
Kenji Noguchi
Nobukazu Tanabe
Yutaka Mano
Katsuaki Ukai
Keiichi Tadokoro
Publication date
01-06-2013
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 3/2013
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-013-0385-y

Other articles of this Issue 3/2013

Clinical Journal of Gastroenterology 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.